Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Internal Medicine
•
Hemostasis
•
Hematology
•
Benign Hematology
•
Hemophilia
What is your recommended management algorithm for bleeding associated with an acquired factor VIII inhibitor?
Answer from: at Community Practice
Fragner et al., Cureus 2022.
Sign in or Register to read more
12811
Related Questions
For mild to moderate hemophilia B, do you routinely screen for inhibitors?
How do you manage DIC associated with an aortic aneurysm while awaiting surgical repair?
How do you treat factor XI deficient patients with surgery or trauma related bleeding?
For an asymptomatic patient discovered during workup for elevated PT/PTT to have mild prothrombin deficiency, would you suggest any preoperative prophylaxis?
What additional testing is recommended with heterozygous HFE C282Y mutation whose ferritin is elevated and transferrin saturation percentage is at baseline?
What subset of sickle cell disease patients are you offering sickle cell disease gene therapy?
Would you evaluate for thrombophilia in patients with incidental splenic infarcts in the setting of known cirrhosis, portal hypertension, and splenomegaly?
How do you decide between HSCT and immunosuppressive therapy for treating hepatitis associated aplastic anemia?
What is the optimal antithrombotic management, if at all, in patients with incidentally identified findings of multiple silent embolic appearing cerebral infarcts?
Would you consider continuing or re-trialing hydroxyurea for sickle cell patients after development of a leg ulcer?